3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 2.390
+0.080 (3.46%)
Oct 9, 2026, 1:39 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 587.75 million as of October 9, 2026. It is the 27,493rd most valuable company in the world and the 1,358th biggest in Hong Kong. Its market cap has decreased by 68.40% in one year.
Market Cap
587.75M
Enterprise Value
267.06M
Revenue
412.66M
Global Rank
Country Rank
#1,358 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 587.75M, a decrease of -91.63%. That is a compound annual growth rate of -47.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 587.75M | -55.06% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cloudbreak Pharma | 1.10B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 807.38M |
| Brii Biosciences | 620.79M |
| B&K Corporation | 493.57M |
| Wuhan YZY Biopharma | 484.62M |
| Uni-Bio Science Group | 417.99M |
| Sirnaomics | 413.27M |